⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9879873 | 1.00 | — | — | |
| SCHEMBL9879655 | 0.92 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL9470683 | 0.83 | — | — | |
| SCHEMBL7508389 | 0.82 | SOAT1 (0.46) | — | |
| SCHEMBL9470219 | 0.80 | — | — | |
| SCHEMBL9872794 | 0.80 | SOAT2 (0.46) | — | |
| SCHEMBL9729102 | 0.79 | — | — | |
| SCHEMBL9873057 | 0.78 | LMNA (0.52) | — | |
| SCHEMBL9873430 | 0.78 | LMNA (0.52) | — | |
| SCHEMBL9113426 | 0.78 | LMNA (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5073565-A | Atherosclerosis, anticholesterol | WARNER-LAMBERT COMPANY (US) | 1991-12-17 | — | — | US | disclosed |